Surgery Partners, Inc. Segment Expenditure Addition To Long Lived Assets
Surgery Partners, Inc. (SGRY) reported Segment Expenditure Addition To Long Lived Assets of $37.80 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Segment Reporting
us-gaap:SegmentExpenditureAdditionToLongLivedAssets · last filed 2026-08-10
- Surgery Partners, Inc. segment expenditure addition to long lived assets for the quarter ending 2026-06-30 was $21.80M, a 6.84% decline year-over-year.
- Surgery Partners, Inc. segment expenditure addition to long lived assets for the quarter ending 2026-03-31 was $16.00M, a 29.52% decline year-over-year.
- Surgery Partners, Inc. segment expenditure addition to long lived assets for the quarter ending 2025-12-31 was $12.80M, a 42.60% decline year-over-year.
- Surgery Partners, Inc. segment expenditure addition to long lived assets for the quarter ending 2025-09-30 was $19.80M, a 1.98% decline year-over-year.
- Surgery Partners, Inc. segment expenditure addition to long lived assets for fiscal 2025 was $78.70M, a 12.94% decline from fiscal 2024.
- Surgery Partners, Inc. segment expenditure addition to long lived assets for fiscal 2024 was $90.40M, a 1.80% increase from fiscal 2023.
- Surgery Partners, Inc. segment expenditure addition to long lived assets for fiscal 2023 was $88.80M, a 10.17% increase from fiscal 2022.
- Surgery Partners, Inc. segment expenditure addition to long lived assets for fiscal 2022 was $80.60M, a 39.93% increase from fiscal 2021.
| Period end | Segment Expenditure Addition To Long Lived Assets 3 month | Segment Expenditure Addition To Long Lived Assets 6 month | Segment Expenditure Addition To Long Lived Assets 9 month | Segment Expenditure Addition To Long Lived Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $21.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $37.80M 10-Q · filed 2026-08-10 | $50.60M derived: sum of 3 quarters · filed 2026-08-10 | $70.40M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $16.00M 10-Q · filed 2026-05-05 | $28.80M derived: sum of 2 quarters · filed 2026-05-05 | $48.60M derived: sum of 3 quarters · filed 2026-05-05 | $72.00M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $12.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $32.60M derived: sum of 2 quarters · filed 2026-03-02 | $56.00M derived: sum of 3 quarters · filed 2026-08-10 | $78.70M 10-K · filed 2026-03-02 |
| 2025-09-30 | $19.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $43.20M derived: sum of 2 quarters · filed 2026-08-10 | $65.90M 10-Q · filed 2025-11-10 | $88.20M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $23.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $46.10M 10-Q · filed 2026-08-10 | $68.40M derived: sum of 3 quarters · filed 2026-08-10 | $88.60M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $22.70M 10-Q · filed 2026-05-05 | $45.00M derived: sum of 2 quarters · filed 2026-05-05 | $65.20M derived: sum of 3 quarters · filed 2026-05-05 | $92.10M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $22.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $42.50M derived: sum of 2 quarters · filed 2026-03-02 | $69.40M derived: sum of 3 quarters · filed 2026-03-02 | $90.40M 10-K · filed 2026-03-02 |
| 2024-09-30 | $20.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $47.10M derived: sum of 2 quarters · filed 2025-11-10 | $68.10M 10-Q · filed 2025-11-10 | $87.90M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-06-30 | $26.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $47.90M 10-Q · filed 2025-08-05 | $67.70M derived: sum of 3 quarters · filed 2026-03-02 | $86.60M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-03-31 | $21.00M 10-Q · filed 2025-05-12 | $40.80M derived: sum of 2 quarters · filed 2026-03-02 | $59.70M derived: sum of 3 quarters · filed 2026-03-02 | $85.50M derived: sum of 4 quarters · filed 2026-03-02 |
| 2023-12-31 | $19.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $38.70M derived: sum of 2 quarters · filed 2026-03-02 | $64.50M derived: sum of 3 quarters · filed 2026-03-02 | $88.80M 10-K · filed 2026-03-02 |
| 2023-09-30 | $18.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $44.70M derived: sum of 2 quarters · filed 2024-11-12 | $69.00M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $25.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $50.10M 10-Q · filed 2024-08-06 | ||
| 2023-03-31 | $24.30M 10-Q · filed 2024-05-07 | |||
| 2022-12-31 | $80.60M 10-K · filed 2025-03-07 | |||
| 2021-12-31 | $57.60M 10-K · filed 2024-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ardent Health, Inc. (ARDT) | United States | $1.478B | 17.91 |
| COMMUNITY HEALTH SYSTEMS INC (CYH) | United States | $0.405B | 1.87 |
| TENET HEALTHCARE CORP (THC) | United States | $20.097B | |
| HCA Healthcare, Inc. (HCA) | United States | $93.934B | 15.49 |